Gilotrif (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Gilotrif drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | afatinib |
| SUBSTANCE NAME: | AFATINIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-07-12 |
| END MARKETING DATE: | 0000-00-00 |
Gilotrif HUMAN PRESCRIPTION DRUG Details:
| Item Description | Gilotrif from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30(mg/1) |
| START MARKETING DATE: | 2013-07-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0137_36142aab-d642-73ab-f5ba-51abe822c15a |
| PRODUCT NDC: | 0597-0137 |
| APPLICATION NUMBER: | NDA201292 |
Other AFATINIB Pharmaceutical Manufacturers / Labelers:
